Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Array Biopharma
Array Biopharma
(ARRY)
Array BioPharma is an American clinical stage, pharmaceutical company that focuses on oncology medication headquartered in Boulder, Colorado. The company is a subsidiary of Pfizer.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Braftovi
Encorafenib
2018-06-27
2029-2033
Colorectal neoplasms
,
Melanoma
Mektovi
Binimetinib
2018-06-27
2023-2033
Melanoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Binimetinib
colorectal neoplasms
,
recurrence
,
colonic neoplasms
,
rectal neoplasms
,
gastrointestinal stromal tumors
,
disease progression
,
gene rearrangement
,
bcr-abl positive chronic myelogenous leukemia
,
lung neoplasms
,
non-small-cell lung carcinoma
,
melanoma
,
neoplasms
,
carcinoma
,
leukemia
,
myeloid leukemia
,
breast neoplasms
,
triple negative breast neoplasms
,
invasive hydatidiform mole
,
plexiform neurofibroma
,
neurofibromatosis 1
,
neurofibromatoses
,
neurofibroma
,
skin neoplasms
,
cutaneous malignant melanoma
,
multiple myeloma
,
plasma cell neoplasms
,
myeloid leukemia acute
,
biliary tract neoplasms
,
lymphoma
Encorafenib
melanoma
,
colorectal neoplasms
,
multiple myeloma
,
plasma cell neoplasms
Sacituzumab
carcinoma
,
breast neoplasms
,
triple negative breast neoplasms
,
invasive hydatidiform mole
Transplatin
carcinoma
,
biliary tract neoplasms
Antithrombin iii
melanoma
Vitamin e
colorectal neoplasms
Ivuxolimab
carcinoma
,
breast neoplasms
,
triple negative breast neoplasms
,
invasive hydatidiform mole
Utomilumab
carcinoma
,
breast neoplasms
,
triple negative breast neoplasms
,
invasive hydatidiform mole
Varlitinib
pancreatic neoplasms
,
neoplasms
Buparlisib
melanoma
Ademetionine
non-small-cell lung carcinoma
,
lung neoplasms
,
brain neoplasms
,
breast neoplasms
,
neoplasm metastasis
Edrecolomab
carcinoma
,
breast neoplasms
,
triple negative breast neoplasms
,
invasive hydatidiform mole
MIRDAMETINIB
colorectal neoplasms
,
neoplasms
Bevifimod
colorectal neoplasms
,
leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia
,
lung neoplasms
,
non-small-cell lung carcinoma
,
neoplasms
,
melanoma
,
lymphoma
FILANESIB
multiple myeloma
,
plasma cell neoplasms
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use